These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24789002)

  • 41. The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial.
    Al-Mutairi N; Nour T
    Expert Opin Biol Ther; 2014 Jun; 14(6):749-56. PubMed ID: 24661040
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk of tuberculosis reactivation during interleukin-17 inhibitor therapy for psoriasis: a systematic review.
    Fowler E; Ghamrawi RI; Ghiam N; Liao W; Wu JJ
    J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):1449-1456. PubMed ID: 32012384
    [TBL] [Abstract][Full Text] [Related]  

  • 43. What are the risks of biologic therapy in rheumatoid arthritis? An update on safety.
    Weisman MH
    J Rheumatol Suppl; 2002 Sep; 65():33-8. PubMed ID: 12236621
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registry.
    Sánchez-Moya AI; García-Doval I; Carretero G; Sánchez-Carazo J; Ferrandiz C; Herrera Ceballos E; Alsina M; Ferrán M; López-Estebaranz JL; Gómez-García F; De la Cueva Dobao P; Carrascosa JM; Vanaclocha F; Belinchón I; Peral F; Dauden E;
    J Eur Acad Dermatol Venereol; 2013 Nov; 27(11):1366-74. PubMed ID: 23134268
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tuberculosis and Biologic Therapies: Anti-Tumor Necrosis Factor-α and Beyond.
    Godfrey MS; Friedman LN
    Clin Chest Med; 2019 Dec; 40(4):721-739. PubMed ID: 31731980
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tuberculosis and anti-TNF treatment: experience of a central London hospital.
    Mankia S; Peters JE; Kang S; Moore S; Ehrenstein MR
    Clin Rheumatol; 2011 Mar; 30(3):399-401. PubMed ID: 20972591
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biologics in dermatology beyond psoriasis.
    Han G
    Cutis; 2014 May; 93(5):E21-7. PubMed ID: 24897148
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tuberculosis in the age of biologic therapy.
    Hernandez C; Cetner AS; Jordan JE; Puangsuvan SN; Robinson JK
    J Am Acad Dermatol; 2008 Sep; 59(3):363-80; quiz 382-4. PubMed ID: 18694676
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Infectious complications of tumor necrosis factor blockade.
    Wallis RS
    Curr Opin Infect Dis; 2009 Aug; 22(4):403-9. PubMed ID: 19491672
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Considering a Biologic: What's a Clinician to Do? Screening and Laboratory Monitoring for Biologic Therapies in the Treatment of Psoriasis.
    Jin A; Zaladonis AG; Hsu S
    Skinmed; 2022; 20(1):14-17. PubMed ID: 35435820
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reactivation of Tuberculosis in Three Cases of Psoriasis after Initiation of Anti-TNF Therapy.
    Shaikha SA; Mansour K; Riad H
    Case Rep Dermatol; 2012 Jan; 4(1):41-6. PubMed ID: 22529801
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association between traditional systemic antipsoriatic drugs and tuberculosis risk in patients with psoriasis with or without psoriatic arthritis: results of a nationwide cohort study from Taiwan.
    Chen YJ; Wu CY; Shen JL; Chen TT; Chang YT
    J Am Acad Dermatol; 2013 Jul; 69(1):25-33. PubMed ID: 23375515
    [TBL] [Abstract][Full Text] [Related]  

  • 53. T cells co-producing Mycobacterium tuberculosis-specific type 1 cytokines for the diagnosis of latent tuberculosis.
    Nemeth J; Winkler HM; Karlhofer F; Selenko-Gebauer N; Graninger W; Winkler S
    Eur Cytokine Netw; 2010 Mar; 21(1):34-9. PubMed ID: 20146988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment guidelines for latent tuberculosis infection.
    ;
    Kekkaku; 2014 Jan; 89(1):21-37. PubMed ID: 24654427
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Infectious risk].
    Calabuig E; Salavert M
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():14-22. PubMed ID: 19080987
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Etanercept provides a more physiological approach in the treatment of psoriasis.
    Altomare G; Ayala F; Berardesca E; Chimenti S; Giannetti A; Girolomoni G; Lotti T; Martini P; Peserico A; Guerra AP; Vena GA
    Dermatol Ther; 2008 Oct; 21 Suppl 2():S1-14. PubMed ID: 18837727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patients with psoriasis are more likely to be treated for latent tuberculosis infection prior to biologics than patients with inflammatory bowel disease.
    Bassukas ID; Kosmidou M; Gaitanis G; Tsiouri G; Tsianos E
    Acta Derm Venereol; 2011 Jun; 91(4):444-6. PubMed ID: 21547342
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prophylaxis for latent tuberculosis infection prior to anti–tumor necrosis factor therapy in low-risk elderly patients with rheumatoid arthritis: a decision analysis.
    Hazlewood GS; Naimark D; Gardam M; Bykerk V; Bombardier C
    Arthritis Care Res (Hoboken); 2013 Nov; 65(11):1722-31. PubMed ID: 23836530
    [TBL] [Abstract][Full Text] [Related]  

  • 59. How frequently do tuberculosis screening tests convert in inflammatory bowel disease patients on anti-tumour necrosis factor-alpha? A pilot study.
    Bermejo F; Algaba A; Chaparro M; Taxonera C; Garrido E; García-Arata I; Guerra I; Gisbert JP; Olivares D; de-la-Poza G; López-Sanromán A
    Dig Liver Dis; 2013 Sep; 45(9):733-7. PubMed ID: 23587496
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden.
    Askling J; Fored CM; Brandt L; Baecklund E; Bertilsson L; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; Romanus V; Klareskog L; Feltelius N
    Arthritis Rheum; 2005 Jul; 52(7):1986-92. PubMed ID: 15986370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.